Frank Iorfino1, Ian B Hickie1, Rico S C Lee1, Jim Lagopoulos1, Daniel F Hermens2. 1. Clinical Research Unit, Brain and Mind Centre, University of Sydney, 94 Mallet Street, Camperdown, NSW, 2050, Australia. 2. Clinical Research Unit, Brain and Mind Centre, University of Sydney, 94 Mallet Street, Camperdown, NSW, 2050, Australia. daniel.hermens@sydney.edu.au.
Abstract
BACKGROUND: Mood and anxiety disorders are leading causes of disability and mortality, due largely to their onset during adolescence and young adulthood and broader impact on functioning. Key factors that are associated with disability and these disorders in young people are social and economic participation (e.g. education, employment), physical health, suicide and self-harm behaviours, and alcohol and substance use. A better understanding of the objective markers (i.e. neurobiological parameters) associated with these factors is important for the development of effective early interventions that reduce the impact of disability and illness persistence. METHODS: We systematically reviewed the literature for neurobiological parameters (i.e. neuropsychology, neuroimaging, sleep-wake and circadian biology, neurophysiology and metabolic measures) associated with functional domains in young people (12 to 30 years) with mood and/or anxiety disorders. RESULTS: Of the one hundred and thirty-four studies selected, 7.6 % investigated social and economic participation, 2.1 % physical health, 15.3 % suicide and self-harm behaviours, 6.9 % alcohol and substance use, whereas the majority (68.1 %) focussed on clinical syndrome. CONCLUSIONS: Despite the predominance of studies that solely examine the clinical syndrome of young people the literature also provides evidence of distinct associations among objective measures (indexing various aspects of brain circuitry) and other functional domains. We suggest that a shift in focus towards characterising the mechanisms that underlie and/or mediate multiple functional domains will optimise personalised interventions and improve illness trajectories.
BACKGROUND: Mood and anxiety disorders are leading causes of disability and mortality, due largely to their onset during adolescence and young adulthood and broader impact on functioning. Key factors that are associated with disability and these disorders in young people are social and economic participation (e.g. education, employment), physical health, suicide and self-harm behaviours, and alcohol and substance use. A better understanding of the objective markers (i.e. neurobiological parameters) associated with these factors is important for the development of effective early interventions that reduce the impact of disability and illness persistence. METHODS: We systematically reviewed the literature for neurobiological parameters (i.e. neuropsychology, neuroimaging, sleep-wake and circadian biology, neurophysiology and metabolic measures) associated with functional domains in young people (12 to 30 years) with mood and/or anxiety disorders. RESULTS: Of the one hundred and thirty-four studies selected, 7.6 % investigated social and economic participation, 2.1 % physical health, 15.3 % suicide and self-harm behaviours, 6.9 % alcohol and substance use, whereas the majority (68.1 %) focussed on clinical syndrome. CONCLUSIONS: Despite the predominance of studies that solely examine the clinical syndrome of young people the literature also provides evidence of distinct associations among objective measures (indexing various aspects of brain circuitry) and other functional domains. We suggest that a shift in focus towards characterising the mechanisms that underlie and/or mediate multiple functional domains will optimise personalised interventions and improve illness trajectories.
Authors: Manreena Kaur; Jim Lagopoulos; Rico Sze Chun Lee; Philip B Ward; Sharon L Naismith; Ian B Hickie; Daniel F Hermens Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2013-07-11 Impact factor: 5.067
Authors: A R Gilbert; G J Moore; M S Keshavan; L A Paulson; V Narula; F P Mac Master; C M Stewart; D R Rosenberg Journal: Arch Gen Psychiatry Date: 2000-05
Authors: Frank P MacMaster; Aileen Russell; Yousha Mirza; Matcheri S Keshavan; S Preeya Banerjee; Rashmi Bhandari; Courtney Boyd; Michelle Lynch; Michelle Rose; Jennifer Ivey; Gregory J Moore; David R Rosenberg Journal: Biol Psychiatry Date: 2005-09-02 Impact factor: 13.382
Authors: Hailey L Dotterer; Rachel C Tomlinson; S Alexandra Burt; Alexander S Weigard; Kelly L Klump; Luke W Hyde Journal: Neuropsychology Date: 2021-05 Impact factor: 3.295
Authors: Hale Yapici Eser; Anil S Kacar; Can M Kilciksiz; Merve Yalçinay-Inan; Dost Ongur Journal: Front Psychiatry Date: 2018-06-27 Impact factor: 4.157
Authors: Rico S C Lee; Daniel F Hermens; Sharon L Naismith; Manreena Kaur; Adam J Guastella; Nick Glozier; Jan Scott; Elizabeth M Scott; Ian B Hickie Journal: BMJ Open Date: 2018-12-18 Impact factor: 2.692
Authors: Ashleigh M Tickell; Cathrin Rohleder; Alexandra Garland; Yun Ju Christine Song; Joanne Sarah Carpenter; Kate Harel; Lisa Parker; Ian B Hickie; Elizabeth Scott Journal: BMJ Open Date: 2021-01-11 Impact factor: 2.692
Authors: Frank Iorfino; Daniel F Hermens; Shane Pm Cross; Natalia Zmicerevska; Alissa Nichles; Caro-Anne Badcock; Josine Groot; Elizabeth M Scott; Ian B Hickie Journal: BMJ Open Date: 2018-03-27 Impact factor: 2.692
Authors: I M J Saris; M Aghajani; S J A van der Werff; N J A van der Wee; B W J H Penninx Journal: Acta Psychiatr Scand Date: 2017-08-02 Impact factor: 6.392
Authors: Joanne S Carpenter; Frank Iorfino; Shane Cross; Alissa Nichles; Natalia Zmicerevska; Jacob J Crouse; Jake R Palmer; Alexis E Whitton; Django White; Sharon L Naismith; Adam J Guastella; Daniel F Hermens; Jan Scott; Elizabeth M Scott; Ian B Hickie Journal: BMJ Open Date: 2020-03-29 Impact factor: 2.692
Authors: Cathrin Rohleder; Yun Ju Christine Song; Jacob J Crouse; Tracey A Davenport; Frank Iorfino; Blake Hamilton; Natalia Zmicerevska; Alissa Nichles; Joanne S Carpenter; Ashleigh M Tickell; Chloe Wilson; Shane P Cross; Adam J Guastella; Dagmar Koethe; F Markus Leweke; Elizabeth M Scott; Ian B Hickie Journal: BMJ Open Date: 2020-06-07 Impact factor: 2.692